NO913004D0 - Syreaddisjonssalter av optisk aktive alaninanilidforbindelser og farmasoeytiske blandinger som inneholder dem. - Google Patents

Syreaddisjonssalter av optisk aktive alaninanilidforbindelser og farmasoeytiske blandinger som inneholder dem.

Info

Publication number
NO913004D0
NO913004D0 NO913004A NO913004A NO913004D0 NO 913004 D0 NO913004 D0 NO 913004D0 NO 913004 A NO913004 A NO 913004A NO 913004 A NO913004 A NO 913004A NO 913004 D0 NO913004 D0 NO 913004D0
Authority
NO
Norway
Prior art keywords
acid addition
optically active
addition salts
compounds
mixtures containing
Prior art date
Application number
NO913004A
Other languages
English (en)
Inventor
Toshiaki Yamaguchi
Tetsuhide Kamijo
Kazuhiko Ikegami
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of NO913004D0 publication Critical patent/NO913004D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255Tartaric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO913004A 1990-08-08 1991-08-01 Syreaddisjonssalter av optisk aktive alaninanilidforbindelser og farmasoeytiske blandinger som inneholder dem. NO913004D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2211208A JP2514855B2 (ja) 1990-08-08 1990-08-08 光学活性なアラニンアニリド誘導体の酸付加塩

Publications (1)

Publication Number Publication Date
NO913004D0 true NO913004D0 (no) 1991-08-01

Family

ID=16602123

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913004A NO913004D0 (no) 1990-08-08 1991-08-01 Syreaddisjonssalter av optisk aktive alaninanilidforbindelser og farmasoeytiske blandinger som inneholder dem.

Country Status (13)

Country Link
EP (1) EP0472325B1 (no)
JP (1) JP2514855B2 (no)
KR (1) KR100192531B1 (no)
AT (1) ATE116296T1 (no)
AU (1) AU646276B2 (no)
CA (1) CA2048714A1 (no)
DE (1) DE69106276T2 (no)
DK (1) DK143991A (no)
ES (1) ES2066363T3 (no)
FI (1) FI101700B1 (no)
HK (1) HK1003787A1 (no)
HU (1) HU213210B (no)
NO (1) NO913004D0 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
ZA942140B (en) * 1993-04-01 1994-10-03 Fisons Corp Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
SG171928A1 (en) 2008-12-24 2011-07-28 Astrazeneca Ab Ethanamine compounds and their use for treating depression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786875A (fr) * 1971-07-28 1973-01-29 Astra Pharma Prod Amide, methode pour sa preparation et ses compositions therapeutiques
US4696930A (en) * 1985-04-12 1987-09-29 Hoffmann-La Roche Inc. N-(heteroarylalkyl)acylanilide derivatives as antiarrhythmic agents
JPS6452797A (en) * 1987-01-06 1989-02-28 Takeda Chemical Industries Ltd Production of crystalline trh-tartrate

Also Published As

Publication number Publication date
CA2048714A1 (en) 1992-02-09
EP0472325A2 (en) 1992-02-26
DE69106276T2 (de) 1995-05-18
AU646276B2 (en) 1994-02-17
DK143991A (da) 1992-02-09
HU213210B (en) 1997-03-28
HUT58292A (en) 1992-02-28
ATE116296T1 (de) 1995-01-15
EP0472325A3 (en) 1992-03-04
EP0472325B1 (en) 1994-12-28
FI101700B (fi) 1998-08-14
AU8145891A (en) 1992-02-13
FI913774A (fi) 1992-02-09
FI101700B1 (fi) 1998-08-14
FI913774A0 (fi) 1991-08-08
ES2066363T3 (es) 1995-03-01
DE69106276D1 (de) 1995-02-09
DK143991D0 (da) 1991-08-07
JPH0495072A (ja) 1992-03-27
HK1003787A1 (en) 1998-11-06
JP2514855B2 (ja) 1996-07-10
HU912640D0 (en) 1992-01-28
KR100192531B1 (ko) 1999-06-15
KR920004334A (ko) 1992-03-27

Similar Documents

Publication Publication Date Title
NO174711C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive pyrimidindionderivater
NO891698L (no) Pyridonkarboksylsyrederivater og fremgangsmaate for deres fremstilling.
DE69008366D1 (de) 2-Aminopyrimidinon-Derivate.
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
DK25386A (da) Pyrazolsulfonamidderivater, fremstilling deraf og herbicid indeholdende samme
NO883146D0 (no) Anti-inflamatorisk aktive arylderivater og fremgangsmaate for deres fremstilling.
AU649882B2 (en) Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments
DK183789A (da) 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse
FI891279A0 (fi) Antivirala tetrahydroimidazol /1,4/ benzodiazepin-2-oner.
NO913004D0 (no) Syreaddisjonssalter av optisk aktive alaninanilidforbindelser og farmasoeytiske blandinger som inneholder dem.
DE3471587D1 (en) Derivatives of benzoic acid, process for their preparation and their use in disinfecting and conserving medicaments
ES8304971A1 (es) Un procedimiento para la preparacion de derivados de tiocarbapenem 3-sustituidos.
MA20369A1 (fr) Compositions a base de derives de la piperidine ,nouveaux derives de la piperidine et leurs procedes de preparation
KR870003986A (ko) α,α-디아릴-4-아릴-4-하이드록시-1-피페리딘부탄아미드, N-옥사이드유도체 및 그 제조방법
NO170630C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutiskaktive 1-(3-(2-sek.-aminoetoksy)-2-tienyl)-3-fenyl-propanoner og syreaddisjonssalter derav
HUT42271A (en) Fungicidal compositions and process for preparing azolyl-(aryloxymethyl)-dimethyl-pentinol derivatives applicable as active substance
TH7859EX (th) อนุพันธ์ต่างๆของพิริโดนคาร์บอกซิลิคแอซิดชนิดออพทิคัลลีแอคทีฟ
TH8805EX (th) อนุพันธ์ต่าง ๆ ของ 3-แอริลออกซิ-เมธิลเซฟาโลสพอริน, การเตรียมของสารเหล่านี้และการใช้เป็นยาของสารเหล่านี้